Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...
Reutlingen, Germany (ots/PRNewswire) - Sustainable market presence for iPoint's software in Japan iPoint-systems, a leading provider of software and services for environmental and social product compliance, and sustainability, today announced a new partnership with the well-established Japanese IT trading company Toyota Tsusho Systems (TTS). With this partnership, ...
Two-thirds of CEOs say that agility is the new currency of business and that if they don't adapt, their business will become irrelevant London (ots/PRNewswire) - CEOs are faced with a stark choice. In the face of unparalleled environmental, economic and technological change, they are looking to grow their businesses by creating the organizational agility to disrupt existing business models and challenge long-held market ...
Lugano, Switzerland (ots) - Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany, France, Benelux, UK and Ireland Swiss-based Helsinn group has granted Chugai ...
Lugano, Switzerland (ots) - The Swiss pharmaceutical Helsinn Group announces today that Taiho Pharmaceutical Co. Ltd., Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist (5- HT3 RA) palonosetron, has launched on the national market the 0.75mg infusion bag formulation of palonosetron hydrochloride (Aloxi®). The infusion bag is an additional formulation to the 0.75mg injectable form already marketed ...
Lugano, Switzerland/Tokyo, Japan (ots) - License Agreement for Japan on Potential New Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) Helsinn Group of Switzerland and Taiho Pharmaceutical Co., Ltd., Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist palonosetron, announce today the signing on April 12, of a licensing agreement granting Taiho the development and ...
Geneva (ots) - Union Bancaire Privée (UBP) announced today three key hires within its Asset Management division, as part of the expansion of its sales activities in Europe and Asia. UBP believes that there is significant potential in European markets and has appointed a new Head of Sales - Europe to focus on augmenting the service it provides to both private and institutional clients in the region. Nicolas ...
Zurich/Jungfraujoch (ots) - In a public protest on Mt. Jungfraujoch, timed to coincide with Japan's Oceans Day, Greenpeace activists demanded a fair sentence trial and an acquittal today for Junichi Sato and Toru Suzuki, two non-violent whale protectors threatened with one year and six months' jail after exposing embezzlement inside Japan's whaling industry. Under the eyes of Japanese tourists on the "Top of ...
Lugano (ots) - The second generation 5-HT3 receptor antagonist palonosetron, already approved as an intravenous solution formulation in more than 60 countries worldwide including US, EU and Japan, obtains the European Marketing Authorization for 0.5 mg oral capsules Palonosetron 0.5 mg soft gelatine capsule oral formulation has been approved by the EMA (European Medicine Agency) for the prevention of nausea and ...
Lugano/Tokyo, Japan (ots) - The second generation 5-HT3 receptor antagonist palonosetron available in more than 50 countries worldwide, including US, EU and Japan Today, Taiho Pharmaceutical Co., Ltd., Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist palonosetron, gained marketing approval in Japan for this drug indicated for the ...
JTI Japan Tobacco International AG
Geneva, Switzerland (ots) - Japan Tobacco International (JTI) today announced the signing of a 15-year agreement with the European Commission and 26 Member States of the EU defining their cooperation to combat the illegal trade of cigarettes in the European territory. "The fight against cigarette smuggling ...